XD cell culture technology: DSM boosted by Amgen license
DSM hints at high yield and cost-cutting benefits in licensing its cell growth technology to Amgen.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
DSM hints at high yield and cost-cutting benefits in licensing its cell growth technology to Amgen.